Jupiter Life Line Hospitals Shows Stabilization Amid Flat Financial Performance and Strong Management Efficiency
Jupiter Life Line Hospitals has recently experienced an evaluation adjustment, reflecting changes in its technical trends. The company reported flat financial performance for the quarter ending March 2025, with a profit after tax of Rs 44.86 crore. It maintains high management efficiency and significant institutional interest.
Jupiter Life Line Hospitals has recently undergone an evaluation adjustment, reflecting changes in its underlying technical trends. The stock, which operates within the hospital and healthcare services industry, has shown a shift in its technical indicators. Notably, the technical trend has transitioned from a mildly bearish stance to a sideways position, indicating a period of stabilization without clear momentum.In terms of performance metrics, the company reported a flat financial performance for the quarter ending March 2025, with a profit after tax of Rs 44.86 crore, which represents a decline of 6.5% compared to the previous quarter's average. Despite this, Jupiter Life Line Hospitals maintains a high management efficiency, evidenced by a return on capital employed (ROCE) of 20.63% and a low debt-to-equity ratio, averaging at 0 times.
The stock's current price stands at Rs 1,421.80, with a 52-week high of Rs 1,759.00 and a low of Rs 1,069.45. Over the past year, the stock has generated a return of 14.28%, while profits have increased by 22%. The company also enjoys a significant institutional holding of 25.67%, suggesting a robust interest from larger investors.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
